Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$89
|
$250B |
3.9x |
9.3x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$26
|
$206B |
3.2x |
8.5x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€104
|
$146B |
3.1x |
10.8x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£14
|
$90.8B |
2.3x |
6.5x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€180
|
$37.9B |
6.1x |
23.4x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$120
|
$11.6B |
4.2x |
-10.1x |
Wantai BioPharm
|
China |
Vaccines & Immunotherapies,
Pharma Diagnostics & Analytics
|
CNY 69
|
$11.3B |
30.2x |
98.7x |
Chongqing Zhifei
|
China |
Vaccines & Immunotherapies
|
CNY 27
|
$9.6B |
2.4x |
17.5x |
Vaxcyte
|
United States of America |
Vaccines & Immunotherapies
|
$80
|
$7.8B |
N/A |
-14.1x |
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$36
|
$7.4B |
2.4x |
-2.0x |
Alk-Abello
|
Denmark |
Vaccines & Immunotherapies
|
DKK 158
|
$5.0B |
6.3x |
24.3x |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2509
|
$4.6B |
10.8x |
36.2x |
Hualan Biological Engineering
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 16
|
$3.9B |
5.4x |
14.0x |
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$3.1B |
82.1x |
N/A |
Sinocelltech Group
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 39
|
$2.7B |
N/A |
N/A |
BioKangtai
|
China |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
CNY 16
|
$2.7B |
6.3x |
22.1x |
Walvax Biotechnology
|
China |
Vaccines & Immunotherapies
|
CNY 12
|
$2.3B |
5.5x |
20.7x |
AstraZeneca India
|
India |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
INR 6869
|
$1.9B |
N/A |
N/A |
SK Bioscience
|
South Korea |
Vaccines & Immunotherapies
|
KRW 47850
|
$1.8B |
8.8x |
-27.0x |
Everest Medicines
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
HKD 45
|
$1.7B |
14.6x |
-23.1x |
Bavarian Nordic
|
Denmark |
Vaccines & Immunotherapies
|
DKK 174
|
$1.6B |
2.1x |
7.2x |
GC Biopharma
|
South Korea |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
KRW 14495
|
$1.4B |
N/A |
N/A |
Changchun BCHT
|
China |
Vaccines & Immunotherapies
|
CNY 24
|
$1.3B |
N/A |
N/A |
Hualan Biological Vaccine
|
China |
Vaccines & Immunotherapies
|
CNY 18
|
$1.3B |
5.6x |
20.2x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$13
|
$1.2B |
4.2x |
25.2x |
AIM Vaccine
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 6
|
$1.1B |
6.3x |
N/A |
Immunocore Holdings
|
Germany |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€29
|
$1.1B |
N/A |
N/A |
Chengdu Kanghua
|
China |
Vaccines & Immunotherapies
|
CNY 56
|
$947M |
N/A |
N/A |
Liaoning Chengda Biotech
|
China |
Vaccines & Immunotherapies
|
CNY 29
|
$920M |
3.9x |
10.6x |
Jinyu Bio-Technology Co.
|
China |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CNY 7
|
$826M |
4.1x |
14.3x |
Celldex Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$737M |
115.6x |
-3.8x |
Keqian Biology
|
China |
Vaccines & Immunotherapies
|
CNY 13
|
$724M |
5.3x |
10.3x |
Valneva
|
France |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
€4
|
$686M |
3.5x |
19.3x |
Renata
|
Bangladesh |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BDT 517
|
$630M |
N/A |
N/A |
Shanghai Hile Bio-Tech
|
China |
Vaccines & Immunotherapies
|
CNY 7
|
$630M |
N/A |
N/A |
Jiangsu Recbio Technology
|
Hong Kong |
Vaccines & Immunotherapies
|
HKD 10
|
$620M |
N/A |
N/A |
Replimune Group
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$14
|
$616M |
199.6x |
-2.8x |
Novavax
|
United States of America |
Vaccines & Immunotherapies
|
$8
|
$604M |
0.9x |
-2.7x |
Immunome
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$569M |
68.0x |
-2.2x |
Candel Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$517M |
N/A |
-14.5x |
Vir Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$516M |
8.2x |
-0.9x |
Luzhu Biotech
|
Hong Kong |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
HKD 22
|
$510M |
N/A |
N/A |
CStone Pharmaceuticals
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 3
|
$444M |
N/A |
N/A |
GlaxoSmithKline Pakistan
|
Pakistan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
PKR 400
|
$433M |
N/A |
N/A |
Medigen Vaccine Biologics
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 47
|
$430M |
21.6x |
92.3x |
Allergy Therapuetics
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$422M |
5.5x |
-15.5x |
HBM Holdings
|
Hong Kong |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
HKD 5
|
$392M |
N/A |
N/A |
Kamada
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 27
|
$382M |
2.3x |
10.8x |
Northwest Biotherapeutics
|
United States of America |
Vaccines & Immunotherapies
|
$0
|
$378M |
N/A |
N/A |
Adimmune
|
Taiwan |
Vaccines & Immunotherapies,
Biopharmaceuticals
|
TWD 24
|
$327M |
6.3x |
-92.2x |
CHO Pharma
|
Taiwan |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
TWD 60
|
$316M |
N/A |
N/A |
Coherus BioSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$297M |
1.2x |
-3.5x |
Cartesian Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$19
|
$290M |
8.3x |
N/A |
Compass Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$274M |
177.1x |
-5.1x |
Tevogen Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$255M |
N/A |
N/A |
Allogene Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$249M |
10282.8x |
-0.9x |
Corvus Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$228M |
2031.1x |
N/A |
Acepodia
|
Taiwan |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TWD 23
|
$223M |
N/A |
N/A |
Faron Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£2
|
$221M |
N/A |
-8.4x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$8
|
$209M |
100.0x |
-2.5x |
CureVac
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$3
|
$202M |
0.4x |
1.1x |
Ourofino
|
Brazil |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
BRL 19
|
$201M |
N/A |
N/A |
Eledon Pharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$4
|
$179M |
N/A |
N/A |
Ocugen
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Genomics & Personalized Medicine
|
$1
|
$166M |
53.6x |
N/A |
INmune Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$160M |
26697.8x |
N/A |
AnaptysBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$19
|
$152M |
2.9x |
-1.0x |
Greenwich LifeSciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$12
|
$152M |
N/A |
N/A |
Turk İlaç
|
Turkey |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
TRY 24
|
$149M |
N/A |
N/A |
Genelux
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$134M |
32670.7x |
N/A |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$11
|
$133M |
0.5x |
-0.4x |
OSE Immunotherapeutics
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€7
|
$124M |
1.3x |
2.1x |
Imugene
|
Australia |
Vaccines & Immunotherapies
|
AUD 0
|
$124M |
78.4x |
-1.5x |
Coya Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$6
|
$123M |
30.4x |
N/A |
Scancell
|
United Kingdom of Great Britain and Northern Ireland |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£0
|
$122M |
21.1x |
-7.6x |
Vaxart
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$122M |
3.5x |
N/A |
Vaxcell-Bio
|
South Korea |
Vaccines & Immunotherapies
|
KRW 9320
|
$122M |
N/A |
N/A |
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$112M |
26.1x |
N/A |
Agenus
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$112M |
1.0x |
N/A |
Instil Bio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$22
|
$110M |
N/A |
N/A |
Celularity
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine,
Vaccines & Immunotherapies
|
$2
|
$109M |
N/A |
N/A |
Invivyd
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$104M |
2.2x |
-0.6x |
Elicio Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$103M |
N/A |
N/A |
AC Immune
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$91.1M |
2.6x |
-2.0x |
Compugen
|
Israel |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
ILS 8
|
$86.6M |
2.3x |
N/A |
LakeShore Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$86.4M |
N/A |
N/A |
Transgene
|
France |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€1
|
$83.0M |
6.2x |
-3.0x |
Anixa Biosciences
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$3
|
$79.5M |
N/A |
N/A |
Immatics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$5
|
$64.7M |
0.6x |
-0.9x |
Cue Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$60.7M |
6.4x |
N/A |
Alligator Bioscience
|
Sweden |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
SEK 0
|
$59.5M |
9.9x |
-3.8x |
European Medical
|
Belgium |
Vaccines & Immunotherapies
|
€7
|
$45.2M |
N/A |
N/A |
Medicenna Therapeutics
|
Canada |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
CAD 1
|
$42.2M |
N/A |
N/A |
MiNK Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$10
|
$38.3M |
N/A |
N/A |
Nektar Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$35.7M |
0.4x |
-0.2x |
Adaptimmune Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$31.6M |
0.2x |
-0.7x |
Intensity Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$31.0M |
N/A |
N/A |
Estrella Immunopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$31.0M |
N/A |
N/A |
Immix Biopharma
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$30.1M |
16.1x |
-1.3x |
HCW Biologics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$0
|
$28.9M |
3.2x |
N/A |
PDS Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$1
|
$25.0M |
N/A |
-0.6x |